Wetzl, V., Faerber, L., Hofmann, F., Schinner, E., & Schlossmann, J. (2015). Differences in the renal antifibrotic signaling of serelaxin and zaprinast. BMC Pharmacol Toxicol.
استشهاد بنمط شيكاغوWetzl, Veronika, Lothar Faerber, Franz Hofmann, Elisabeth Schinner, و Jens Schlossmann. "Differences in the Renal Antifibrotic Signaling of Serelaxin and Zaprinast." BMC Pharmacol Toxicol 2015.
MLA استشهادWetzl, Veronika, et al. "Differences in the Renal Antifibrotic Signaling of Serelaxin and Zaprinast." BMC Pharmacol Toxicol 2015.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.